99624-67-6

Basic information

• Product Name: paeonimetabolin I
• Synonyms: paeonimetabolin I
• CAS NO: 99624-67-6
• Molecular Formula: C₁₀H₁₄O₄
• Molecular Weight: 198.2158
• Mol File: 99624-67-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 323.6°Cat760mmHg
• Flash Point: 129.2°C
• Appearance: /
• Density: 1.371g/cm³
• Vapor Pressure: 2.03E-05mmHg at 25°C
• Refractive Index: 1.566
• CAS DataBase Reference: paeonimetabolin I(CAS DataBase Reference)
• NIST Chemistry Reference: paeonimetabolin I(99624-67-6)
• EPA Substance Registry System: paeonimetabolin I(99624-67-6)

Safety Data

• Hazardous Substances Data: 99624-67-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Paeonimetabolin I is used as a therapeutic agent for its anti-inflammatory properties, targeting the treatment of inflammatory disorders. Its ability to modulate the immune response and reduce oxidative stress contributes to its potential as a treatment option for various inflammatory conditions.
Used in Neurological Applications:
Paeonimetabolin I is used as a neuroprotective agent for its potential to treat neurological disorders. Its neuroprotective activities may help in mitigating the effects of neurodegenerative diseases and promoting the health of the nervous system.
Further research is necessary to fully understand the mechanisms of action and explore the potential clinical uses of Paeonimetabolin I in these applications.

InChI:InChI=1/C10H14O4/c1-5-6-3-10(12)9(2,4-7(6)11)13-8(5)14-10/h5-6,8,12H,3-4H2,1-2H3

Upstream product

• 38642-49-8 benzoylpaeoniflorin 
• 23180-57-6 paeoniflorin 
• 139685-64-6 (3aS,4aR,7S,7aR,8aR)-2,2,3a,7-Tetramethyl-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139685-66-8 (3aS,5R,6R,7aR)-2,2,3a-Trimethyl-6-((S)-1-methyl-allyl)-hexahydro-benzo[1,3]dioxol-5-ol 
• 139618-34-1 (3aS,5R,6R,7aR)-2,2,3a-Trimethyl-6-((R)-1-methyl-allyl)-hexahydro-benzo[1,3]dioxol-5-ol 
• 139685-67-9 (2S,5R)-2-Hydroxy-2-methyl-5-((S)-1-methyl-allyl)-cyclohexane-1,4-dione 
• 139618-30-7 (3aR,4R,6S,7aR)-6-Isopropenyl-2,2,3a-trimethyl-4-phenylselanyl-hexahydro-benzo[1,3]dioxole 
• 139618-33-0 (3aR,4R,4aS,7aR,8aR)-4-Iodo-2,2,3a-trimethyl-7-methylene-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139618-32-9 2-((3aR,5S,7aS)-2,2,7a-Trimethyl-3a,4,5,7a-tetrahydro-benzo[1,3]dioxol-5-yl)-prop-2-en-1-ol 
• 139685-63-5 (3aS,4aR,7aR,8aR)-2,2,3a-Trimethyl-7-methylene-hexahydro-furo[2',3':4,5]benzo[1,2-d][1,3]dioxol-6-one 
• 139618-31-8 (3aR,5S,7aS)-2,2,7a-Trimethyl-5-(2-methyl-oxiranyl)-3a,4,5,7a-tetrahydro-benzo[1,3]dioxole 
• 24120-79-4 (1R,2R,4S,6S)-(-)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-ol 
• 139618-35-2 (2S,5R)-2-Hydroxy-2-methyl-5-((R)-1-methyl-allyl)-cyclohexane-1,4-dione 
• 23180-57-6 paeoniflorin 

Downstream Products

• 111950-56-2 7S-paeonimetaboline-6-O-3,5-dinitrophenyl carbamate 

Relevant articles and documents

Enantiospecific syntheses of paeonilactone A, paeonilactone B, 7S-paeonimetabolin-I, and 7R-paeonimetabolin-I from R-(-)-carvone

The first enantiospecific syntheses of the title monoterpenes have been accomplished starting with R-(-)-carvone, which made their absolute structures unequivocal.